Resistance Candida spp. for amphotericin B in cancer patients

Resistance Candida spp. for amphotericin B in cancer patients

We have tested 253 strains (13 species) Candida spp. Determination of the minimum inhibitory concentration of amphotericin B was performed by 2 methods: epsilometric method (Etest®, BioMerieux, France) and on the instrument the Vitek2 (BioMerieux, France). In general, resistance was detected in 5 st...

Full description

Bibliographic Details
Main Authors:	N. S. Bagirova, N. V. Dmitrieva
Format:	Article
Language:	Russian
Published:	Journal Infectology 2016-04-01
Series:	Журнал инфектологии
Subjects:	antifungal susceptibility candida spp. amphotericin b resistance minimum inhibitory concentration e test vitek 2 breakpoints
Online Access:	https://journal.niidi.ru/jofin/article/view/458

Similar Items

Determination of resistance Candida spp. to antifungal agents with systemic action epsilometric method (E-test) with the species-specific characteristics of Candida
by: N. S. Bagirova, et al.
Published: (2015-11-01)

Recent developments on the anti-Candida effect of amphotericin B combined with a second drug - a mini-review
by: DANIEL C. DE MORAES
Published: (2023-05-01)

Susceptibility of Susceptibility of Susceptibility of Candida Candida spp. Oral isolates for azolic spp. Oral isolates for azolic antifungals and amphotericin B
by: Vivian Fernandes Furlletti, et al.
Published: (2016-01-01)

The Micronaut–AM antifungal susceptibility testing method does not overestimate amphotericin B resistance in Candida auris
by: Paraskevi Mantzana, et al.
Published: (2024-05-01)

Colonization and antifungals susceptibility patterns of Candida species isolated from hospitalized patients in ICUs and NICUs
by: Ali Zarei Mahmoudabadi, et al.
Published: (2015-07-01)

Susceptibility to amphotericin B of Candida spp. strains isolated in Ceará, Northeastern Brazil
by: Cecília Rocha da Silva, et al.
Published: (2013-04-01)

In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles
by: Andrew M. Borman, et al.
Published: (2021-04-01)

Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.
by: Célia F. Rodrigues, et al.
Published: (2017-12-01)

Susceptibility to amphotericin B of Candida spp. strains isolated in Ceará, Northeastern Brazil
by: Cecília Rocha da Silva, et al.
Published: (2013-04-01)

Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents
by: Semiha Ozkan, et al.
Published: (2005-05-01)

The Antifungal Effect of Silver, Copper Nanoparticles, and Their Combination and in combination with Amphotericin B against Candida albicans In Vitro and in Animal Model
by: Hossein Soltani, et al.
Published: (2018-02-01)

MIC, candida, antifungal The minimum inhibitory concentration of different antifungal agents against Candida species
by: vian badr barzinji
Published: (2019-09-01)

Synergism effect of tunicamycin and amphotericin B causes suppression to the MP65 and ERG3 gene in oral associated-Candida albicans and C. dubliniensis
by: Nor-Zulaila Che Omran, et al.
Published: (2016-11-01)

Insight into Virulence and Mechanisms of Amphotericin B Resistance in the <i>Candida haemulonii</i> Complex
by: Yuyan Huang, et al.
Published: (2024-08-01)

Synergistic Combination of Amphotericin B and Antiseptic Miramistin May Be Effective in the Fight Against Drug-Resistant Isolates of Candida Fungi
by: M. A. Кirsanova, et al.
Published: (2022-12-01)

Effect of Nebulized Amphotericin B in Critically ill Patients With Respiratory Candida spp. De-colonization: A Retrospective Analysis
by: Hangxiang Du, et al.
Published: (2021-09-01)

Study on the antifungal effect of amphotericin B combined with fluconazole at different time points
by: ZHU Chengguang, et al.
Published: (2021-01-01)

Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
by: Lucas Soares Bezerra, et al.
Published: (2020-05-01)

Letter to the editor: lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris
by: Meng Zhu, et al.
Published: (2024-12-01)

Polishing the Therapy of Onychomycosis Induced by <i>Candida</i> spp.: Amphotericin B–Loaded Nail Lacquer
by: Aleph M. S. Souza, et al.
Published: (2021-05-01)

Microdilution procedure for antifungal susceptibility testing of Paracoccidioides brasiliensis to amphotericin b and itraconazole
by: E Takahagi-Nakaira, et al.
Published: (2009-01-01)

Combination of Posaconazole and Amphotericin B in the Treatment of <i>Candida glabrata</i> Biofilms
by: Célia F. Rodrigues, et al.
Published: (2018-12-01)

Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
by: Uma BM, et al.
Published: (2024-07-01)

Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals
by: Patrício Godoy, et al.
Published: (2003-04-01)

Reavaliação da suscetibilidade de Candida à anfotericina B: estudo comparativo com isolados de três hospitais do estado do Rio Grande do Sul Reevaluation of Candida susceptibility to amphotericin B: comparative study using isolates from three hospitals in the state of Rio Grande do Sul
by: Everton Boff, et al.
Published: (2008-02-01)

ANTIFUNGAL SUSCEPTIBILITY PATTERNS AND VIRULENCE FACTORS OF CLINICAL CANDIDA SPP. ISOLATES
by: Olga Burduniuc
Published: (2021-11-01)

Efficacy of oral amphotericin B for refractory atopic dermatitis with specific IgE to Candida albicans and food allergens in sera
by: Kazuko Kitamura, et al.
Published: (1997-01-01)

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation
by: Maria Siopi, et al.
Published: (2023-06-01)

Susceptibility to antifungal agents of Candida spp. from blood and feces collected in Novi Sad in 3-year period (2008-2010)
by: Jelesić Zora Z., et al.
Published: (2011-01-01)

Severe Sporotrichosis Caused by <i>Sporothrix brasiliensis</i>: Antifungal Susceptibility and Clinical Outcomes
by: Vivian Fichman, et al.
Published: (2022-12-01)

An evaluation of manual and mechanical methods to identify Candida spp. from human and animal sources Avaliação de métodos de identificação de leveduras do gênero Candida de origem humana e animal
by: Geraldo dos Santos Oliveira, et al.
Published: (2006-12-01)

The synergistic effects of hydroxychavicol and amphotericin B towards yeast-hyphae transition and the germination of Candida albicans
by: Wan H.A.W. Harun, PhD, et al.
Published: (2023-10-01)

Efficacy of ultraviolet radiation on drug susceptibility of Candida Spp. to itraconazole, fluconazole and amphotericin B
by: Nowrozi H, et al.
Published: (2013-11-01)

Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study
by: P Badiee, et al.
Published: (2011-12-01)

A study of In vitro antifungal susceptibility patterns of dermatophytic fungi at a tertiary care center in Western India
by: Shital Poojary, et al.
Published: (2019-01-01)

Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics
by: Jinhan Yu, et al.
Published: (2023-05-01)

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021-08-01)

In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in <i>Candida</i> spp.
by: Iacopo Franconi, et al.
Published: (2023-12-01)

Drug susceptibility testing of clinical isolates of Candida albicans against Amphotericin B and Ketoconazole by microdilution and disk diffusion methods
by: A Kazemi, et al.
Published: (2017-05-01)

Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model
by: Ainara Hernando-Ortiz, et al.
Published: (2024-01-01)